Astrazeneca plc AZN.US AI Analysis
BetaUS StockHealthcare
(No presentation for AZN)
AZN Value Score
3
24
15
Average Growth
Analysis Conclusion
The stock holds a moderate value rating. If you have positions, consider retaining; for new ones, wait for a value score above 4.
AZN Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of AZN from 2007-01-01 till Now
- 164.16%
- Cumulative Return
- 5.41%
- Annual Return
- 20.41%
- Volatility
- 0.27
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to June, 2025. (Total Trades: 4)
| AZN | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 75% | 46% | 55% |
| Avg Return | 28.8% | 46.2% | 58.8% |
| Avg Profit | 40.3% | 148.3% | 131.8% |
| Avg Loss | -5.6% | -39.9% | -31.2% |
| Avg Risk-Reward Ratio | 715% | 371.3% | 422.8% |